uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted March 20, 2020

Seller of Rejuvenation Pills Settles Charges of Making False Claims

Health Center, Inc. has agreed to halt their allegedly deceptive advertising claims about three "cure-all" health and wellness products that targeted older consumers nationwide after the Federal Trade Commission (FTC) filed a complaint. As part of the settlement, the company is barred from making false and unsubstantiated health claims about the products, and will pay $5,000.

According the FTC's complaint, Health Center, Inc. sold three products through telemarketing calls and its websites: Rejuvi-Cell (an oral spray), Rejuvi-Seal (a caplet), and Rejuvi-Stem (a tablet). These products were promoted with claims that they could treat or cure many diseases, including cancer, diabetes, Alzheimer's disease, heart disease, obesity, rheumatoid arthritis, and depression, but these claims were not supported by scientific evidence. The director of the FTC's Bureau of Consumer Protection warned, "This company told older adults that its products could treat nearly any disease or health condition -- but that was not true."

The proposed order bans Health Center, Inc. from making claims about its products without competent and reliable scientific evidence. It also imposes an $8.62 million judgment against Health Center, Inc. which will be partially suspended after they pay $5,000.

See Related Recalls and Warnings:

Seller of TrueAloe and AloeCran Settles Charges of Making False Claims

Advocare to Pay $150 Million to Settle Charges of Operating a Pyramid Scheme

CVS Settles Lawsuit Over Claims Its Omega-3 Supplement Improves Memory

For more information, use the link below.